Marta Baldrighi joined Medicines for Europe in 2020, where she works as Policy and Science Officer in the Biosimilar Medicines and Value Added Medicines Groups. Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value-added industries. In 2020, Marta completed her PhD in Medicine at the University of Cambridge (UK), working on immunological responses in sterile inflammation. She also holds a MSc degree in Medicinal Chemistry and Pharmaceutical Technology from the University of Pavia (Italy) and an advanced degree in Life Sciences from the IUSS Institute of Pavia (Italy)